Helping Startups Launch What’s Next

Getting a new chemical product off the ground can come with challenges, especially when you're moving fast, juggling funding, and building something from scratch.

We work closely with startups to turn ideas into real products that are ready for the next step.

From formulation, scale-up, or small-batch manufacturing, we bring the technical expertise and flexibility to help early-stage teams make real progress, without slowing down.

Build What’s Never Been Built

Patents exist today because of what we’ve made possible

The Challenge of Building What’s Never Been Built

Startups are often building something that’s never been built before. There’s no blueprint, no safety net and usually, not much budget either.

The pressure is real:

Solve a problem in a way no one else has
Be first to market, and do it fast
Keep costs down while figuring it out on the fly
Make smart decisions with limited information
Get creative when off-the-shelf solutions won’t cut it

It’s a huge task. And it requires more than vendors or suppliers, it takes true partners who can think through tough challenges, move quickly, and still deliver quality work.

How Parimer Helps

Early-Stage Synthesis & Route Development

We help figure out how to make your chemical, drug or molecule reliably and develop clear processes, refine the process, and get consistent batches ready for real use.

Material Production

We deliver high-quality material without locking you into huge timelines or budgets, so you can move forward without getting stuck.

Development

Our focus is on the chemistry. We develop the ingredients that go into pharma products and back them with methods that deliver consistent results..

Regulatory Support

If it’s your first time through IND or preclinical steps, we’ll help you figure out what’s needed, what’s next, and how to stay on track.

GMP Manufacturing

When GMP-grade is required, we make sure it’s done right. Our systems are ready to support IND and clinical timelines, without unnecessary complexity.